1. E. Afgan, et al., The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2018 update. Nucleic Acids Res 46, W537–W544 (2018).
2. S. M. Albelda, C. W. Smith, P. A. Ward, Adhesion molecules and inflammatory injury. FASEB J 8, 504–512 (1994).
3. K. Allton, et al., Trim24 targets endogenous p53 for degradation. Proc Natl Acad Sci U S A 106, 11612–11616 (2009).
4. S. Appikonda, K. N. Thakkar, M. C. Barton, Regulation of gene expression in human cancers by TRIM24. Drug Discov Today Technol 19, 57–63 (2016).
5. S. Appikonda, et al., Cross-talk between chromatin acetylation and SUMOylation of tripartite motif-containing protein 24 (TRIM24) impacts cell adhesion. J Biol Chem 293, 7476–7485 (2018).
6. B. Bell, I. Sadowski, Ras-responsiveness of the HIV-1 LTR requires RBF-1 and RBF-2 binding sites. Oncogene 13, 2687–2697 (1996).
7. W. Bernhard, K. Barreto, S. Raithatha, I. Sadowski, An upstream YY1 binding site on the HIV-1 LTR contributes to latent infection. PLoS One 8, e77052 (2013).
8. P. D. Bieniasz, T. A. Grdina, H. P. Bogerd, B. R. Cullen, Recruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription. Proc Natl Acad Sci U S A 96, 7791–7796 (1999).
9. D. G. Brooks, P. A. Arlen, L. Gao, C. M. R. Kitchen, J. A. Zack, Identification of T cell-signaling pathways that stimulate latent HIV in primary cells. Proc Natl Acad Sci U S A 100, 12955–12960 (2003).
10. S. Buratowski, Progression through the RNA polymerase II CTD cycle. Mol Cell 36, 541–546 (2009).
11. J. Chen, T. Malcolm, M. C. Estable, R. G. Roeder, I. Sadowski, TFII-I regulates induction of chromosomally integrated human immunodeficiency virus type 1 long terminal repeat in cooperation with USF. J Virol 79, 4396–4406 (2005).
12. T. W. Chun, et al., Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc Natl Acad Sci U S A 94, 13193–13197 (1997).
13. M. S. Dahabieh, M. Ooms, T. Malcolm, V. Simon, I. Sadowski, Identification and functional analysis of a second RBF-2 binding site within the HIV-1 promoter. Virology 418, 57–66 (2011).
14. A. D. Douglass, R. D. Vale, Single-molecule microscopy reveals plasma membrane microdomains created by protein-protein networks that exclude or trap signaling molecules in T cells. Cell 121, 937–950 (2005).
15. Y. Durocher, S. Perret, A. Kamen, High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells. Nucleic Acids Res 30, E9 (2002).
16. D. Dutta, et al., Recruitment of calcineurin to the TCR positively regulates T cell activation. Nat Immunol 18, 196–204 (2017).
17. M. C. Estable, et al., Human immunodeficiency virus type 1 long terminal repeat variants from 42 patients representing all stages of infection display a wide range of sequence polymorphism and transcription activity. J Virol 70, 4053–4062 (1996).
18. M. C. Estable, M. Hirst, B. Bell, M. V. O’Shaughnessy, I. Sadowski, Purification of RBF-2, a transcription factor with specificity for the most conserved cis-element of naturally occurring HIV-1 LTRs. J Biomed Sci 6, 320–332 (1999).
19. D. Finzi, et al., Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278, 1295–1300 (1997).
20. A. Grakoui, et al., The immunological synapse: a molecular machine controlling T cell activation. Science 285, 221–227 (1999).
21. A. C. Groner, et al., TRIM24 Is an Oncogenic Transcriptional Activator in Prostate Cancer. Cancer Cell 29, 846–858 (2016).
22. P. Hashemi, et al., Compounds producing an effective combinatorial regimen for disruption of HIV-1 latency. EMBO Mol Med 10, 160–174 (2018).
23. S. Hatakeyama, TRIM Family Proteins: Roles in Autophagy, Immunity, and Carcinogenesis. Trends Biochem Sci 42, 297–311 (2017).
24. B. Herquel, et al., Transcription cofactors TRIM24, TRIM28, and TRIM33 associate to form regulatory complexes that suppress murine hepatocellular carcinoma. Proc Natl Acad Sci U S A 108, 8212–8217 (2011).
25. M. Hirst, et al., A two-hybrid system for transactivator bait proteins. Proc Natl Acad Sci U S A 98, 8726–8731 (2001).
26. A. K. Jain, K. Allton, A. D. Duncan, M. C. Barton, TRIM24 is a p53-induced E3-ubiquitin ligase that undergoes ATM-mediated phosphorylation and autodegradation during DNA damage. Mol Cell Biol 34, 2695–2709 (2014).
27. B. Joos, et al., HIV rebounds from latently infected cells, rather than from continuing low-level replication. Proc Natl Acad Sci U S A 105, 16725–16730 (2008).
28. Y. Kanno, et al., Tripartite Motif Containing 24 Acts as a Novel Coactivator of the Constitutive Active/Androstane Receptor. Drug Metab Dispos 46, 46–52 (2018).
29. J. Karn, The molecular biology of HIV latency: breaking and restoring the Tat-dependent transcriptional circuit. Curr Opin HIV AIDS 6, 4–11 (2011).
30. M. Kikuchi, et al., TRIM24 mediates ligand-dependent activation of androgen receptor and is repressed by a bromodomain-containing protein, BRD7, in prostate cancer cells. Biochim Biophys Acta 1793, 1828–1836 (2009).
31. D. W. Kim, B. H. Cochran, Extracellular signal-regulated kinase binds to TFII-I and regulates its activation of the c-fos promoter. Mol Cell Biol 20, 1140–1148 (2000).
32. S. B. Laskey, R. F. Siliciano, A mechanistic theory to explain the efficacy of antiretroviral therapy. Nat Rev Microbiol 12, 772–780 (2014).
33. D. Lv, et al., TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma. Nat Commun 8, 1454 (2017).
34. T. Malcolm, J. Chen, C. Chang, I. Sadowski, Induction of chromosomally integrated HIV-1 LTR requires RBF-2 (USF/TFII-I) and Ras/MAPK signaling. Virus Genes 35, 215–223 (2007).
35. T. Malcolm, J. Kam, P. S. Pour, I. Sadowski, Specific interaction of TFII-I with an upstream element on the HIV-1 LTR regulates induction of latent provirus. FEBS Lett 582, 3903–3908 (2008).
36. U. Mbonye, J. Karn, Transcriptional control of HIV latency: cellular signaling pathways, epigenetics, happenstance and the hope for a cure. Virology 454–455, 328–339 (2014).
37. U. R. Mbonye, et al., Phosphorylation of CDK9 at Ser175 enhances HIV transcription and is a marker of activated P-TEFb in CD4(+) T lymphocytes. PLoS Pathog 9, e1003338 (2013).
38. U. Mbonye, et al., Cyclin-dependent kinase 7 (CDK7)-mediated phosphorylation of the CDK9 activation loop promotes P-TEFb assembly with Tat and proviral HIV reactivation. J Biol Chem 293, 10009–10025 (2018).
39. C. R. Monks, B. A. Freiberg, H. Kupfer, N. Sciaky, A. Kupfer, Three-dimensional segregation of supramolecular activation clusters in T cells. Nature 395, 82–86 (1998).
40. M. Ott, M. Geyer, Q. Zhou, The control of HIV transcription: keeping RNA polymerase II on track. Cell Host Microbe 10, 426–435 (2011).
41. T. N. Pathiraja, et al., TRIM24 links glucose metabolism with transformation of human mammary epithelial cells. Oncogene 34, 2836–2845 (2015).
42. L. A. Pereira, K. Bentley, A. Peeters, M. J. Churchill, N. J. Deacon, A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter. Nucleic Acids Res 28, 663–668 (2000).
43. Y. H. Ping, T. M. Rana, DSIF and NELF interact with RNA polymerase II elongation complex and HIV-1 Tat stimulates P-TEFb-mediated phosphorylation of RNA polymerase II and DSIF during transcription elongation. J Biol Chem 276, 12951–12958 (2001).
44. B. S. Razooky, A. Pai, K. Aull, I. M. Rouzine, L. S. Weinberger, A hardwired HIV latency program. Cell 160, 990–1001 (2015).
45. A. L. Roy, M. Meisterernst, P. Pognonec, R. G. Roeder, Cooperative interaction of an initiator-binding transcription initiation factor and the helix-loop-helix activator USF. Nature 354, 245–248 (1991).
46. A. L. Roy, Biochemistry and biology of the inducible multifunctional transcription factor TFII-I: 10 years later. Gene 492, 32–41 (2012).
47. S. Roy, C. K. Sen, H. Kobuchi, L. Packer, Antioxidant regulation of phorbol ester-induced adhesion of human Jurkat T-cells to endothelial cells. Free Radic Biol Med 25, 229–241 (1998).
48. I. Sadowski, F. B. Hashemi, Strategies to eradicate HIV from infected patients: elimination of latent provirus reservoirs. Cell Mol Life Sci 76, 3583–3600 (2019).
49. I. Sadowski, P. Lourenco, T. Malcolm, Factors controlling chromatin organization and nucleosome positioning for establishment and maintenance of HIV latency. Curr HIV Res 6, 286–295 (2008).
50. S. Thénot, C. Henriquet, H. Rochefort, V. Cavaillès, Differential interaction of nuclear receptors with the putative human transcriptional coactivator hTIF1. J Biol Chem 272, 12062–12068 (1997).
51. J. Tisserand, et al., Tripartite motif 24 (Trim24/Tif1α) tumor suppressor protein is a novel negative regulator of interferon (IFN)/signal transducers and activators of transcription (STAT) signaling pathway acting through retinoic acid receptor α (Rarα) inhibition. J Biol Chem 286, 33369–33379 (2011).
52. W.-W. Tsai, et al., TRIM24 links a non-canonical histone signature to breast cancer. Nature 468, 927–932 (2010).
53. UNAIDS, Global HIV & AIDS statistics — Fact sheet (2022) (January 15, 2022).
54. E. Verdin, P. Paras, C. Van Lint, Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation. EMBO J 12, 3249–3259 (1993).
55. D. Vullhorst, A. Buonanno, Multiple GTF2I-like repeats of general transcription factor 3 exhibit DNA binding properties. Evidence for a common origin as a sequence-specific DNA interaction module. J Biol Chem 280, 31722–31731 (2005).
56. L. S. Weinberger, T. Shenk, An HIV feedback resistor: auto-regulatory circuit deactivator and noise buffer. PLoS Biol 5, e9 (2007).
57. Y.-D. Wen, W. D. Cress, A. L. Roy, E. Seto, Histone deacetylase 3 binds to and regulates the multifunctional transcription factor TFII-I. J Biol Chem 278, 1841–1847 (2003).
58. J. K. Wong, et al., Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 278, 1291–1295 (1997).
59. T. Yu, et al., Modulation of M2 macrophage polarization by the crosstalk between Stat6 and Trim24. Nat Commun 10, 4353 (2019).
60. S. A. Yukl, et al., HIV latency in isolated patient CD4+ T cells may be due to blocks in HIV transcriptional elongation, completion, and splicing. Sci Transl Med 10, eaap9927 (2018).
61. Q. Zhu, et al., TRIM24 facilitates antiviral immunity through mediating K63-linked TRAF3 ubiquitination. J Exp Med217, e20192083 (2020).